A Study in Healthy Infants of the Safety Tolerability and Immunogenicity of Haemophilus Influenzae Type b/Hepatitis B Vaccine Manufactured With a Modified Process.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 May 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Hib-hepatitis B vaccine (Primary) ; Aluminium hydroxyphosphate sulfate
Indications Haemophilus infections; Hepatitis B
Focus Pharmacodynamics; Registrational
Sponsors Merck & Co; Merck Sharp & Dohme

26 Aug 2011 Results published in Vaccine.
14 Jul 2009 Trial phase changed from II to III as reported by ClinicalTrials.gov.
14 Apr 2009 Actual initiation date changed from Mar 2007 to Dec 2006 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com